Target intelligence / Profile preview

MT-ND2 pseudogene 32 (MTND2P32)

Target: MTND2P32
Molecular classification: Other (Pseudogene)

Overview

MT-ND2 pseudogene 32 (MTND2P32) is a nuclear-encoded pseudogene corresponding to the mitochondrial NADH: ubiquinone oxidoreductase core subunit 2 (MT-ND2). Unlike the functional MT-ND2 gene in mitochondrial DNA, MTND2P32 does not encode a protein and does not participate in electron transport or cellular respiration. Pseudogenes such as MTND2P32 may arise from duplication or retrotransposition events, but generally lack transcriptional or biological activity. There is no current evidence supporting MTND2P32 as a clinically relevant drug target, disease gene, or biomarker.

Other names: MT-ND2 Pseudogene 32MTND2P32

Beyond the preview

Go deeper on MT-ND2 pseudogene 32 (MTND2P32).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-ND2 pseudogene 32 (MTND2P32).

Explore the full profile